To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Amniotic Membrane market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global amniotic membrane market is estimated to hold a value of US$ 11.12 Bn in 2032 and is expected to expand at a CAGR of 14% during the forecast period from 2022 to 2032. Growth in the market can be attributed to the increasing cases of accidents and the rising awareness about the benefits offered provided by the amniotic membrane.
Report Attributes |
Details |
Estimated Market Value of the Global Amniotic Membrane in 2022 |
USD 3 Bn |
Estimated Market Value of the Global Amniotic Membrane in 2032 |
USD 11.12 Bn |
Projected CAGR from 2022 to 2032 |
14% |
Key Players of the Global Amniotic Membrane Market |
|
The advantages offered by the amniotic membranes, such as; their ability to reduce pain, can lead to the growing adoption of tissue-based products to heal surgical wounds. Furthermore, increasing expenditure in R&D in regenerative medicine and stem cells is expected to augment the market size in the forecast period.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
According to Fact.MR- a market research and competitive intelligence provider- the global amniotic membrane market surged at a CAGR of 12% from 2015 to 2021, securing a market value of US$ 2 Bn. The market is expected to grow owing to the increasing population of glaucoma patients.
The analysis at Fact.MR reveals that the market is likely to hold a market value of US$ 11.12 Bn in 2032. The expansion of the market can be attributed to the growing geriatric population, which has resulted in a rise in ophthalmology surgeries, posing a significant demand for these tissue-based products.
The outbreak of COVID-19 brought a negative impact on the market owing to the disruptions caused in the supply chain. Temporary halt in supply and manufacturing affected the market by restraining revenue generation. However, the key players are taking various initiatives to counter the challenges posed by the COVID-19 lockdown.
Increased Demand for Ophthalmology Amniotic Membrane to Boost the Market
The growing demand for these tissue-based products in ophthalmic surgeries due to their fast recovery properties is anticipated to play a significant role in driving the market during the forecast period. Moreover, the increasing demand for surgeries for aesthetic appeal is anticipated to boost the market.
As per the American Society of Plastic Surgeons, there were about 17.7 million cosmetics in 2018. Further, the growing prevalence of ocular disorders is expected to produce high demand for wound care techniques like amniotic membrane transplant, which is likely to expand the market during the forecast period.
A CDC report from 2019 reveals that there are approximately 1 million people in the U.S suffering from eye infections annually. In addition, the increasing initiative to improve the effectiveness of amniotic membranes is likely to bolster the growth of the market. For instance, Surgenex manufactured SurGraft, which is a dehydrated amniotic membrane providing a better shelf-life to enhance the longevity of the amniotic membrane.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
High Amniotic Membrane Prices to Hamper the Market in the Forecast Period
The high amniotic membrane treatment costs is expected to hamper the market growth during the forecast period. Further, the risk of infections associated with the application of amniotic membrane is projected to affect the market negatively. As per a study published in Clinical Ophthalmology Journal in 2020, there is a higher risk of being infected with diseases such as; Hepatitis C, Hepatitis B, HIV, and Prion.
Besides, complications associated with amniotic membrane such as; the formation of Haemotomas, Granulomas, and Hypopon are other causes that can impede the market growth. In addition, the inadequate classification system for clinical conditions further inhibits the market expansion during the forecast period.
Increasing Demand for Amniotic Eye Treatment to Boost the Market in North America
North America is anticipated to hold a significant market share during the forecast period owing to the increasing demand for amniotic eye treatment. The region is anticipated to have secured a revenue share of about 30% in 2022.
The growing focus to advance the healthcare sector, increasing awareness among the population about efficient alternative technologies are other salient causes augmenting the market in the forecast period.
Among all, the U.S is likely to make the most significant contribution in boosting the market in North America. The growing demand for ophthalmology amniotic eye treatment in the U.S is expected to be a salient cause augmenting the market size during the forecast period.
Increasing Chronic Diseases in Europe to Boost the Regional Market
The market in Europe is expected to secure the second-highest revenue share and is likely to exhibit a steady CAGR of 10% during the forecast period. The expansion of the market in Europe can be attributed to the adoption of universal health care systems, thereby growing the market in the region.
The W.H.O reveals that diseases such as diabetes, cancer, cardiovascular disease, chronic respiratory ailments claim about 86% of lives in the region. Therefore, there has been a significant rise in demand for efficient methods to reduce the fatalities and counter dieses, thereby expanding the market in the region.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Rising Application of Amniotic Membranes in ASCs to Boost the Hospital Segment
Based on end-use, the market is anticipated to be dominated by the hospital segment during the forecast period. As per the assessment at Fact.MR, the segment is expected to secure about 38% of the market share in 2022.
The growth of the segment can be attributed to the increasing number of visits by patients to the hospital to procure primary health care facilities. Escalating usage of amniotic membranes in ASCs is expected to be another salient factor boosting the market expansion in the coming time. In addition, the ease to use the medical equipment is projected to support the segment growth in the forthcoming time.
Surgical Wounds to comprise bulk of Amniotic Membranes Deployment
Based on application, the market can be segmented into surgical wounds, ophthalmology, and others. As per the estimations at Fact.MR, the surgical wounds segment is expected to procure the largest revenue share of about 36%.
The expansion of the segment can be attributed to the increasing incidences of infectious and chronic diseases. These equipment are used in ophthalmic surgeries for fast recovery and to lessen inflammation. In addition, the growing number of surgeries to enhance the aesthetic appeal is predicted to further expand the market size in the forecast period.
The global players of the amniotic membrane market adopt various strategies to enhance their global reach and secure the forefront position in the market. Partnership, acquisitions, and collaboration are some of the most adopted approaches to expand their market footprint. Some of the recent developments among the key players are:
Attribute |
Details |
Forecast Period |
2022-2032 |
Historical Data |
2015-2021 |
Key Regions Covered |
|
Key Countries Covered |
|
Key Segments Covered |
|
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
- Related Reports -
By 2021, amniotic membrane sales were valued at US$ 2 Bn, according to Fact.MR
By 2022, demand for amniotic membranes is expected to reach US$ 3 Bn
From 2015-2021, amniotic membrane sales expanded at a CAGR of 12%, as per Fact.MR
From 2022-2032, sales of amniotic membranes are likely to expand at a CAGR of 14%
Fact MR. estimates the amniotic membrane market to secure a market value of USD 11.12 Bn by 2032
As of 2022, North America is expected to account for 30% of the global amniotic membrane revenue
In Europe, demand for amniotic membranes is expected to surge at a CAGR of 10%
Surgical wounds are expected to account for 36% of global amniotic membrane sales